The tumor suppressor PTEN acts as a regulator of AKT activity by dephosphorylating PIP3, although it is frequently downregulated or lost during tumor progression, contributing to deregulation of the pathway in cancer cells. The gene discussed is AKT1; the disease is neoplasm.